Clinical Trials Directory

Trials / Completed

CompletedNCT02793674

HFNC Flow Titration and Effort of Breathing in the PICU

High-Flow Nasal Cannula Flow Titration and Effort of Breathing in the Pediatric Intensive Care Unit

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
21 (actual)
Sponsor
Children's Hospital Los Angeles · Academic / Other
Sex
All
Age
3 Years
Healthy volunteers
Not accepted

Summary

High-flow nasal cannula (HFNC) is a method of non-invasive respiratory support used to decrease the effort of breathing (EOB) in patients with a wide variety of respiratory diseases in the pediatric intensive care unit. While its use has shown association with decreased rates of mechanical ventilation, there is a paucity of data examining its direct effect upon objective measurements of EOB. This study will aim to evaluate objective measurements of EOB in response to different levels of HFNC support, characterize the natural course of respiratory diseases treated with HFNC, evaluate changes in EOB secondary to the administration of supplemental medical therapies used in conjunction with HFNC, and compare different physiologic metrics for quantifying EOB in patients on HFNC.

Conditions

Interventions

TypeNameDescription
DEVICEFisher & Paykel high flow nasal cannulaMeasurements of effort of breathing will be obtained at flow rates of 0.5, 1.0, 1.5, and 2.0 L/kg/min. Adequate time will be allowed at each flow rate for stabilization of EOB and flow levels will be trialed in a random order, each being trialed for approximately 5 minutes.
DEVICEVapotherm high flow nasal cannulaMeasurements of effort of breathing will be obtained at flow rates of 0.5, 1.0, 1.5, and 2.0 L/kg/min. Adequate time will be allowed at each flow rate for stabilization of EOB and flow levels will be trialed in a random order, each being trialed for approximately 5 minutes.

Timeline

Start date
2014-09-01
Primary completion
2016-07-01
Completion
2016-07-01
First posted
2016-06-08
Last updated
2024-10-30
Results posted
2018-08-02

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02793674. Inclusion in this directory is not an endorsement.